The role of duloxetine in stress urinary incontinence: A systematic review and meta-analysis

International Urology and Nephrology

Volumn 45, Issue 3, 2013, Pages 679-686

  Li, Jinhong ^a   Yang, Lu ^a   Pu, Chunxiao ^a   Tang, Yin ^a   Yun, Haichao ^a   Han, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Duloxetine; Medical management; Meta analysis; Stress urinary incontinence; Systematic review

Indexed keywords

CHOLINERGIC RECEPTOR; DOPAMINE UPTAKE INHIBITOR; DULOXETINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; THIOPHENE;

ARTICLE; CONSTIPATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRESS INCONTINENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; XEROSTOMIA;

FEMALE; HUMANS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TREATMENT OUTCOME; URINARY INCONTINENCE, STRESS; URINATION;

EID: 84879501420     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0410-6     Document Type: Article

References (25)

1. Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5-26
2. Buckley BS, Lapitan MC, Epidemiology Committee of the Fourth International Consultation on Incontinence, Paris (2008) Prevalence of urinary incontinence in men, women, and children: current evidence-findings of the fourth international consultation on incontinence. Urology 2010(76):265-270
3. Imamura M, Abrams P, Bain C, et al. (2010) Systematic review and economic modeling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 14:No.40
4. Abrams P, Cardozo L, Khoury S, Wein A (2005) International consultation on incontinence, 3rd edn. Health Publication Ltd, Plymouth
5. Mah SY, Lee KS, Choo MS et al (2006) Duloxetine versus placebo for the treatment of Korean women with stress predominant urinary incontinence. Korean J Urol 47(5):527-535
6. Thor KB, Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloraloseanesthetized female cat. J Pharmacol Exp Ther 274:1014-1024
7. Lin AT, Sun MJ, Tai HL, et al. (2008) Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial. BMC Urology 8:2 (25 January 2008)
8. Millard RJ, Moore K, Rencken R et al (2004) Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 93(3):311-318
9. van Kerrebroeck P, Abrams P, Lange R et al (2004) Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 111:249-257
10. Cardozo L, Drutz HP, Baygani SK et al (2004) Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 104(3):511-519
11. Dmochowski RR, Miklos JR, Nortan PA et al (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170:1259-1263
12. Norton PA, Zinner NR, Yalcin I et al (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40-48
13. Higgins J, Green S (2005) editors. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. In the Cochrane Library, Issue 3, Chichester, United Kingdom: John Wiley and Sons
14. Mariappan P, Alhasso AA, Grant A et al (2009) Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults (Review). Cochrane Lib 1:1-56
15. Kinchen KS, Obenchain R, Swindle R (2005) Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. Int Urogynecol J 16:337-344
16. Schagen van Leeuwen JH, Lange RR, Jonasson AF, Chen WJ et al (2008) Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. Maturitas 60:138-147
17. Cardozo L, Lange R, Voss S, Beardsworth A et al (2010) Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin 26(2):253-261
18. Pradhan A, Jain P, Latthe PM (2012) Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J 23:831-841
19. Ho CP, Bhatia NN (2012) Development of stem cell therapy for stress urinary incontinence. Curr Opin Obstet Gynecol 24(5):311-317
20. Katofiasc MA, Nissen J, Audia JE et al (2002) Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 71:1227-1236
21. Wyman JF, Fantl JA, McClish DK et al (1998) Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am J Obstet Gynecol 179(4):999-1007
22. Kondo A, Yokoyama E, Koshiba K et al (1997) Bladder neck support prosthesis: a nonoperative treatment for stress or mixed urinary incontinence. J Uro 157(3):824-827
23. Bodell DM, Leach GE (2002) Needle suspension procedures for female incontinence. Urol Clin North Am 29(3):575-584
24. Rodriguez LV, Raz S (2003) Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaire. J Urol 170(3):857-863
25. Itano N, Berman C, Rodriguez LV et al (2003) Polypropylene sling for the treatment of stress urinary incontinence: intermediate-term results. J Urol 169S:270